Delcath Systems ROE 2010-2024 | DCTH
Current and historical return on equity (ROE) values for Delcath Systems (DCTH) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Delcath Systems ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2024-09-30 | $-0.03B | $0.01B | -309.09% |
| 2024-06-30 | $-0.06B | $0.00B | -373.33% |
| 2024-03-31 | $-0.05B | $0.02B | -350.00% |
| 2023-12-31 | $-0.05B | $0.02B | -671.43% |
| 2023-09-30 | $-0.04B | $0.03B | -2933.33% |
| 2023-06-30 | $-0.03B | $0.00B | 550.00% |
| 2023-03-31 | $-0.04B | $-0.01B | 533.33% |
| 2022-12-31 | $-0.04B | $-0.01B | 1600.00% |
| 2022-09-30 | $-0.03B | $-0.01B | -1466.67% |
| 2022-06-30 | $-0.03B | $-0.00B | -476.92% |
| 2022-03-31 | $-0.03B | $0.01B | -245.45% |
| 2021-12-31 | $-0.03B | $0.01B | -169.49% |
| 2021-09-30 | $-0.03B | $0.01B | -156.52% |
| 2021-06-30 | $-0.03B | $0.02B | -166.67% |
| 2021-03-31 | $-0.02B | $0.02B | -173.58% |
| 2020-12-31 | $-0.02B | $0.02B | -384.00% |
| 2020-09-30 | $-0.01B | $0.00B | 666.67% |
| 2020-06-30 | $-0.01B | $0.01B | 128.00% |
| 2020-03-31 | $-0.01B | $-0.01B | 63.49% |
| 2019-12-31 | $-0.01B | $-0.01B | 50.63% |
| 2019-09-30 | $-0.03B | $-0.02B | 150.00% |
| 2019-06-30 | $-0.03B | $-0.03B | 183.78% |
| 2019-03-31 | $-0.04B | $-0.02B | 245.61% |
| 2018-12-31 | $-0.02B | $-0.02B | 205.13% |
| 2018-09-30 | $-0.03B | $-0.01B | 504.35% |
| 2018-06-30 | $-0.03B | $-0.01B | 660.00% |
| 2018-03-31 | $-0.03B | $-0.01B | 1866.67% |
| 2017-12-31 | $-0.05B | $0.00B | 18400.00% |
| 2017-09-30 | $-0.03B | $-0.00B | 4533.33% |
| 2017-06-30 | $-0.02B | $0.00B | -2933.33% |
| 2017-03-31 | $-0.03B | $-0.00B | -1542.86% |
| 2016-12-31 | $-0.02B | $-0.00B | -450.00% |
| 2016-09-30 | $-0.02B | $0.00B | -230.77% |
| 2016-06-30 | $-0.02B | $0.01B | -177.78% |
| 2016-03-31 | $-0.01B | $0.01B | -118.18% |
| 2015-12-31 | $-0.01B | $0.01B | -107.69% |
| 2015-09-30 | $-0.01B | $0.01B | -78.69% |
| 2015-06-30 | $-0.02B | $0.01B | -88.24% |
| 2015-03-31 | $-0.02B | $0.02B | -80.00% |
| 2014-12-31 | $-0.02B | $0.02B | -76.60% |
| 2014-09-30 | $-0.02B | $0.02B | -75.47% |
| 2014-06-30 | $-0.02B | $0.03B | -77.88% |
| 2014-03-31 | $-0.02B | $0.03B | -72.73% |
| 2013-12-31 | $-0.03B | $0.03B | -93.02% |
| 2013-09-30 | $-0.04B | $0.03B | -121.01% |
| 2013-06-30 | $-0.04B | $0.03B | -141.38% |
| 2013-03-31 | $-0.05B | $0.04B | -194.29% |
| 2012-12-31 | $-0.05B | $0.02B | -252.38% |
| 2012-09-30 | $-0.06B | $0.03B | -253.33% |
| 2012-06-30 | $-0.05B | $0.02B | -201.90% |
| 2012-03-31 | $-0.04B | $0.02B | -160.75% |
| 2011-12-31 | $-0.03B | $0.03B | -100.84% |
| 2011-09-30 | $-0.03B | $0.04B | -98.36% |
| 2011-06-30 | $-0.03B | $0.02B | -103.23% |
| 2011-03-31 | $-0.04B | $0.03B | -120.69% |
| 2010-12-31 | $-0.05B | $0.03B | -191.84% |
| 2010-09-30 | $-0.04B | $0.04B | -163.44% |
| 2010-06-30 | $-0.04B | $0.02B | -313.04% |
| 2010-03-31 | $-0.03B | $0.01B | -425.00% |
| 2009-12-31 | $-0.02B | $0.02B | -303.45% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.370B | $0.002B |
| Delcath Systems, Inc. has developed a system, the Delcath system, to isolate the liver from the general circulatory system and to administer chemotherapy and other therapeutic agents directly to the liver. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $205.491B | 25.07 |
| Intuitive Surgical (ISRG) | United States | $191.931B | 100.35 |
| Alcon (ALC) | Switzerland | $42.651B | 28.54 |
| Edwards Lifesciences (EW) | United States | $41.817B | 26.55 |
| IQVIA Holdings (IQV) | United States | $37.469B | 20.64 |
| IDEXX Laboratories (IDXX) | United States | $36.904B | 43.46 |
| DexCom (DXCM) | United States | $30.627B | 46.12 |
| Waters (WAT) | United States | $23.276B | 34.42 |
| STERIS (STE) | Ireland | $21.284B | 24.50 |
| SONOVA HOLDING (SONVY) | Switzerland | $20.097B | 0.00 |
| Hologic (HOLX) | United States | $17.200B | 18.58 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $14.078B | 14.45 |
| Sysmex ADR (SSMXY) | Japan | $13.104B | 41.09 |
| Globus Medical (GMED) | United States | $11.291B | 28.59 |
| Penumbra (PEN) | United States | $9.244B | 90.55 |
| Masimo (MASI) | United States | $9.076B | 43.92 |
| Teleflex (TFX) | United States | $8.687B | 13.85 |
| Glaukos (GKOS) | United States | $7.647B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $4.828B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.639B | 26.30 |
| Veracyte (VCYT) | United States | $3.314B | 99.44 |
| Inari Medical (NARI) | United States | $3.126B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.714B | 15.67 |
| Nihon Kohden (NHNKY) | Japan | $2.347B | 17.83 |
| TransMedics (TMDX) | United States | $2.344B | 74.30 |
| Elekta AB (EKTAY) | Sweden | $2.216B | 19.92 |
| Tandem Diabetes Care (TNDM) | United States | $2.108B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.881B | 9.83 |
| RxSight (RXST) | United States | $1.599B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.363B | 0.00 |
| Artivion (AORT) | United States | $1.216B | 80.56 |
| Pulse Biosciences (PLSE) | United States | $1.152B | 0.00 |
| OPKO Health (OPK) | United States | $1.078B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.852B | 14.48 |
| Paragon 28 (FNA) | United States | $0.837B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.712B | 16.78 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.699B | 0.00 |
| IRadimed (IRMD) | United States | $0.693B | 37.47 |
| AxoGen (AXGN) | United States | $0.646B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.597B | 0.00 |
| SiBone (SIBN) | United States | $0.570B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.544B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.515B | 30.30 |
| Treace Medical Concepts (TMCI) | United States | $0.493B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.441B | 23.84 |
| ClearPoint Neuro (CLPT) | United States | $0.404B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.351B | 0.00 |
| CVRx (CVRX) | United States | $0.331B | 0.00 |
| NeuroPace (NPCE) | United States | $0.327B | 0.00 |
| Inogen (INGN) | United States | $0.227B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.215B | 0.00 |
| Accuray (ARAY) | United States | $0.210B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.203B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.187B | 0.00 |
| Nevro (NVRO) | United States | $0.163B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.157B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.143B | 15.26 |
| Spectral Diagnostics (EDTXF) | Canada | $0.105B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.094B | 0.00 |
| LENSAR (LNSR) | United States | $0.090B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.089B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.084B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.084B | 0.00 |
| 908 Devices (MASS) | United States | $0.083B | 0.00 |
| InspireMD (NSPR) | Israel | $0.082B | 0.00 |
| Hyperfine (HYPR) | United States | $0.073B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.071B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.053B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.048B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.045B | 0.00 |
| Envoy Medical (COCH) | United States | $0.044B | 0.00 |
| Spectral AI (MDAI) | United States | $0.038B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.038B | 0.00 |
| Neuronetics (STIM) | United States | $0.035B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.034B | 0.00 |
| Precision Optics (POCI) | United States | $0.032B | 0.00 |
| NexGel (NXGL) | United States | $0.025B | 0.00 |
| DarioHealth (DRIO) | United States | $0.023B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.019B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.017B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.015B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.015B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.012B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.012B | 0.00 | |
| T2 Biosystems (TTOO) | United States | $0.011B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.009B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| Nuwellis (NUWE) | United States | $0.006B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.005B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.004B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.003B | 0.00 |
| Avinger (AVGR) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |